BioSpace News Archive

New chemistry for DNA analysis will empower forensic laboratories to overcome common challenges including degraded and contaminated samples.

Emergent Health Corp. announced today the appointment of former Kraft Foods Director of National Accounts Charlie McMenamin to its Board of Directors.

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced today that it will be presenting virtually at the upcoming Sequire Biotechnology Conference on Thursday, February 2nd, at 10:00 AM ET.

Biosero, Inc. and Virscidian, developer of solutions to automate LC/MS (liquid chromatography and mass spectrometry) decision-driven workflows, today announced a collaboration and co-marketing agreement through which the companies will support fully automated analytical workflows for medicinal chemistry.

Halberd Corporation (OTC PINK:HALB) confirmed that animal testing at Mississippi State University (MSU) will focus on Halberd’s patent-pending nasal spray to mitigate the effects of Traumatic Brain Injury (TBI), when administered shortly after sustaining a head Injury.

WaterIQ Technologies ™, the leader in next-generation ultrasonic solutions to combat harmful algae and biofilm without the use of chemicals, today announced the addition of three members to its newly formed Scientific Advisory Board.

LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology has published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes – one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.

Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (“SEC”) in connection with its upcoming General Meeting of Shareholders scheduled to be held on February 28, 2023.

COTA, Inc.today announced its membership in the Clinical Research Data Sharing Alliance (CRDSA), a nonprofit, cross-industry alliance of biopharma companies, data sharing platforms, academic institutions, and service and technology partners.

Eyenovia, Inc., a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in connection with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, showcased the Microdose Array Print Technology at CES 2023 in Las Vegas, Nevada, from Jan. 5-8.